New research from Baker Tilly has confirmed what many urologists were already able to reasonably assume: The reduced associated inpatient and complications-related costs of bipolar TURP Plasma Resection (as with the Olympus Plasma Oval Button) are adding up to lower costs per procedure. More than $1,000, in fact.
Baker Tilly Virchow Krause, LLP, an economic consulting firm, showed that average total bipolar TURP cost per procedure is approximately $1,100 lower than monopolar TURP, amounting to a 23.1 percent cost savings. The study, entitled, "Transurethral Resection of the Prostate (TURP): A Cost Analysis of Bipolar and Monopolar Technologies," complements the established body of published literature that has shown superior clinical benefits of bipolar TURP compared to monopolar TURP, including lower frequency of adverse events and complications.
Bipolar plasma resection is a type of TURP procedure that has benefits because of the safety of performing resection or vaporization in saline. It is designed for use when surgical intervention is indicated for benign prostatic enlargement or benign prostatic hyperplasia (BPH), which affects approximately 60 percent of men age 60 or older. Olympus' plasma portfolio provides a safe, cost-efficient, and easy-to-use solution for bipolar TURP. The newest addition to the plasma portfolio, the Plasma-OvalButton, features a novel shape, combined with an easy-to-learn vaporization technique, which results in well-coagulated, smooth tissue.
A key driver of the resulting savings for bipolar TURP is shown to be related to the fact that fewer bipolar cases are admitted as inpatient procedures, 1 2.7 percent vs. 21.5 percent (p<001). Additionally, the study showed that bipolar procedures, when admitted as inpatient procedures, are less expensive than monopolar procedures.
In addition to cost savings per TURP procedure, the Olympus plasma platform can be used for other Urology and Gynecology procedures, including transurethral resection of bladder tumors (TURBT) and transcervical resection. This system versatility may bring additional cost savings to facilities already utilizing the Olympus plasma vaporization and resection platform for TURP due to minimal outlay of additional capital cost.